Paolo Zamboni, M.D., from the University of Ferrara Hospital in Italy, and colleagues examined the efficacy and safety of venous PTA in patients with MS and CCSVI. One hundred fifteen patients with relapsing-remitting MS were recruited and randomized to venous PTA (76 patients) or catheter venography without venous angioplasty (sham; 39 patients).